|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash, current portion | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash, net of current portion | ||||||||||||||||||||
| Restricted cash, net of current portion | ||||||||||||||||||||
| Mineral properties and equipment, net | ||||||||||||||||||||
| Property, plant & equipment and mineral properties, net | ||||||||||||||||||||
| Kinetic separation intellectual property | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Asset retirement obligations, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Asset retirement obligations, net of current portion | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Deferred contingent consideration | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common shares, no par value, unlimited authorized shares, 71,854,194 shares issued as of June 30, 2026 and December 31, 2025, and 71,853,888 shares outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
